{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:33:54Z","timestamp":1791588834092,"version":"4.3.4"},"reference-count":15,"publisher":"Termedia Sp. z.o.o.","issue":"2","license":[{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cent Eur J Immunol"],"abstract":"<jats:p>The spectrum of liver involvement during coronavirus disease 2019 (COVID-19) is broad and mainly includes elevated liver enzymes and cholestasis. Severe acute respiratory syndrome corona- virus-2 (SARS-CoV-2) infection most often leads to a transient moderate increase in liver enzymes that is not accompanied by disturbances in the synthetic function of the liver. However, there is increasing evidence that SARS-CoV-2 infection is associated with the development of autoimmune disorders. The pathogenesis of autoimmune hepatobiliary diseases is not fully understood, taking into account genetic and environmental factors such as viral infections. We present a pediatric case of autoimmune sclerosing cholangitis (ASC), which was diagnosed 2 months after SARS-CoV-2 infection. To the best of our knowledge, ASC potentially triggered by COVID-19 has not been reported in pediatric patients. Further studies are needed to describe the clinical impact of the development of autoimmune liver diseases potentially associated with SARS-CoV-2 infection in pediatric patients. Our observations indicate that children with liver injury potentially caused by COVID-19 require long-term monitoring of liver function parameters.<\/jats:p>","DOI":"10.5114\/ceji.2022.116368","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T02:45:59Z","timestamp":1655261159000},"page":"183-187","source":"Crossref","is-referenced-by-count":5,"title":["Autoimmune sclerosing cholangitis might be triggered by SARS-CoV-2 infection in a child \u2013 a case report"],"prefix":"10.5114","volume":"47","author":[{"given":"Katarzyna","family":"Zdanowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bobrus-Chociej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kopiczko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miros\u0142awa","family":"U\u015bcinowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Tomczuk-Ostapczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Janica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna Maria","family":"\u0141otowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Bia\u0142okoz-Kalinowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz Marek","family":"Lebensztejn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3061","published-online":{"date-parts":[[2022,5,30]]},"reference":[{"key":"ref-1538767","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN Hepatology Committee Position Statement","volume":"66","author":"Mieli-Vergani G","year":"2018","unstructured":"Mieli-Vergani G, Vergani D, Baumann U, et al. (2018): Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN Hepatology Committee Position Statement. J Pediatr Gastroenterol Nutr 66: 345-360.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref-1538768","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaut.2018.10.007","article-title":"Juvenile autoimmune hepatitis: a comprehensive review","volume":"95","author":"Sokollik C","year":"2018","unstructured":"Sokollik C, McLin VA, Vergani D, et al. (2018): Juvenile autoimmune hepatitis: a comprehensive review. J Autoimmun 95: 69-76.","journal-title":"J Autoimmun"},{"key":"ref-1538769","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson JK","year":"2018","unstructured":"Dyson JK, Beuers U, Jones DEJ, et al. (2018): Primary sclerosing cholangitis. Lancet 391: 2547-2559.","journal-title":"Lancet"},{"key":"ref-1538770","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.NPR.0000722316.63824.f9","article-title":"Elevated liver function tests in COVID-19: Causes, clinical evidence, and potential treatments","volume":"46","author":"Clark R","year":"2021","unstructured":"Clark R, Waters B, Stanfill AG (2021): Elevated liver function tests in COVID-19: Causes, clinical evidence, and potential treatments. Nurse Pract 46: 21-26.","journal-title":"Nurse Pract"},{"key":"ref-1538771","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1111\/liv.14887","article-title":"Liver involvement in children with SARS-COV-2 infection: Two distinct clinical phenotypes caused by the same virus","volume":"41","author":"Perez A","year":"2021","unstructured":"Perez A, Cantor A, Rudolph B, et al. (2021): Liver involvement in children with SARS-COV-2 infection: Two distinct clinical phenotypes caused by the same virus. Liver Int 41: 2068-2075.","journal-title":"Liver Int"},{"key":"ref-1538772","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5223\/pghn.2021.24.2.119","article-title":"Coronavirus disease 2019-liver injury-literature review and guidelines based on the recommendations of hepatological societies","volume":"24","author":"Pawlowska J","year":"2021","unstructured":"Pawlowska J, Lebensztejn DM, Jankowska I (2021): Coronavirus disease 2019-liver injury-literature review and guidelines based on the recommendations of hepatological societies. Pediatr Gastroenterol Hepatol Nutr 24: 119-126.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"ref-1538773","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s43066-021-00144-1","article-title":"Long-term clinical and biochemical residue after COVID-19 recovery","volume":"11","author":"Gameil MA","year":"2021","unstructured":"Gameil MA, Marzouk RE, Elsebaie AH, Rozaik SE (2021): Long-term clinical and biochemical residue after COVID-19 recovery. Egypt Liver J 11: 74.","journal-title":"Egypt Liver J"},{"key":"ref-1538774","doi-asserted-by":"crossref","first-page":"642922","DOI":"10.3389\/fphys.2021.642922","article-title":"A high percentage of patients recovered from COVID-19 but discharged with abnormal liver function tests","volume":"12","author":"Gan Q","year":"2021","unstructured":"Gan Q, Gong B, Sun M, et al. (2021): A high percentage of patients recovered from COVID-19 but discharged with abnormal liver function tests. Front Physiol 12: 642922.","journal-title":"Front Physiol"},{"key":"ref-1538775","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3390\/microorganisms9091958","article-title":"Liver involvement in children with COVID-19 and multisystem inflammatory syndrome: a single-center Bulgarian observational study","volume":"9","author":"Lazova S","year":"2021","unstructured":"Lazova S, Alexandrova T, Gorelyova-Stefanova N, et al. (2021): Liver involvement in children with COVID-19 and multisystem inflammatory syndrome: a single-center Bulgarian observational study. Microorganisms 9: 1958.","journal-title":"Microorganisms"},{"key":"ref-1538776","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jmv.27292","article-title":"Autoimmune complications of COVID-19","volume":"94","author":"Yazdanpanah N","year":"2022","unstructured":"Yazdanpanah N, Rezaei N (2022): Autoimmune complications of COVID-19. J Med Virol 94: 54-62.","journal-title":"J Med Virol"},{"key":"ref-1538777","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1111\/liv.15044","article-title":"Autoimmune hepatitis triggered by COVID-19: A report of two cases","volume":"41","author":"Kaba\u00e7am G","year":"2021","unstructured":"Kaba\u00e7am G, Wahlin S, Efe C (2021): Autoimmune hepatitis triggered by COVID-19: A report of two cases. Liver Int 41: 2527-2528.","journal-title":"Liver Int"},{"key":"ref-1538778","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/liv.14721","article-title":"COVID-19 and liver disease: Not all evil comes to harm","volume":"41","author":"Marabotto E","year":"2021","unstructured":"Marabotto E, Ziola S, Sheijani AD, Giannini EG (2021): COVID-19 and liver disease: Not all evil comes to harm. Liver Int 41: 237-238.","journal-title":"Liver Int"},{"key":"ref-1538779","first-page":"002264","article-title":"Autoimmune hepatitis-primary biliary cholangitis overlap syndrome triggered by COVID-19","volume":"8","author":"Singh B","year":"2021","unstructured":"Singh B, Kaur P, Maroules M (2021): Autoimmune hepatitis-primary biliary cholangitis overlap syndrome triggered by COVID-19. Eur J Case Rep Intern Med 8: 002264.","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref-1538780","first-page":"2099","volume-title":"Hepatology","author":"Efe C","year":"2021\/2022","unstructured":"Efe C, Dhanasekaran R, Lammert C, et al. (2021\/2022): Outcome of COVID-19 in patients with autoimmune hepatitis: an international multicenter study. Hepatology 73: 2099-2109. Erratum In: Hepatology 75: 774."},{"key":"ref-1538781","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jhep.2021.01.021","article-title":"contributing Members and Collaborators of ERN RARE-LIVER\/COVID-Hep\/SECURE-Cirrhosis, Moon AM, Webb GJ, Lohse AW (2021): SARS-CoV-2 infection in patients with autoimmune hepatitis","volume":"74","author":"Marjot T","unstructured":"Marjot T, Buescher G, Sebode M, et al.; contributing Members and Collaborators of ERN RARE-LIVER\/COVID-Hep\/SECURE-Cirrhosis, Moon AM, Webb GJ, Lohse AW (2021): SARS-CoV-2 infection in patients with autoimmune hepatitis. J Hepatol 74: 1335-1343.","journal-title":"J Hepatol"}],"container-title":["Central European Journal of Immunology"],"original-title":[],"link":[{"URL":"https:\/\/ceji.termedia.pl\/pdf-149517-129653","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ceji.termedia.pl\/pdf-149517-129653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:32:26Z","timestamp":1767947546000},"score":1,"resource":{"primary":{"URL":"https:\/\/ceji.termedia.pl\/Autoimmune-sclerosing-cholangitis-might-be-triggered-by-SARS-CoV-2-infection-in-a,149517,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"alternative-id":["149517"],"URL":"https:\/\/doi.org\/10.5114\/ceji.2022.116368","relation":{},"ISSN":["1426-3912","1644-4124"],"issn-type":[{"value":"1426-3912","type":"print"},{"value":"1644-4124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,30]]}}}